The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
Effect of paracentesis on the survival of patients with terminal cancer and ascites: A propensity score-weighted analysis of the EASED study.
 
Ken Masuda
Honoraria - Chugai Pharma
 
Hiroto Ishiki
Speakers' Bureau - Daiichi Sankyo/Lilly; Mundipharma
 
Naosuke Yokomichi
No Relationships to Disclose
 
Takuhiro Yamaguchi
Stock and Other Ownership Interests - STATCOM
Consulting or Advisory Role - CAC Croit Corporation; Japan Tobacco Inc; Kowa; Ono Pharmaceutical
Speakers' Bureau - Asahi Kasei; Daiichi Sankyo; Nipro Corporation; Takeda; Tsumura & Co.
Research Funding - 3H Clinical Trial; 3H Medi Solution (Inst); A2 Healthcare (Inst); AC Medical (Inst); ClinChoice; Eisai; Facet Biotech (Inst); Hemp Kitchen (Inst); intellim (Inst); Japan Media Corporation (Inst); Japan Tobacco Inc (Inst); Medidata Solutions, Inc (Inst); Medrio (Inst); NIPRO CORPORATION (Inst); Nobori Ltd. (Inst); Ono Pharmaceutical (Inst); Otsuka; Puravida Technologies (Inst); Senju Pharmaceutical; Welby (Inst)
 
Tetsuya Ito
No Relationships to Disclose
 
Hana Takatsu
No Relationships to Disclose
 
Koji Amano
No Relationships to Disclose
 
Shuji Hiramoto
No Relationships to Disclose
 
Takashi Kawaguchi
No Relationships to Disclose
 
Masanori Mori
Honoraria - Chugai Pharma; Daiichi Sankyo; Kyowa Hakko Kirin; Lilly Japan; Shionogi
 
Yosuke Matsuda
No Relationships to Disclose
 
Takashi Yamaguchi
No Relationships to Disclose